BACKGROUND: Antimicrobial use in long-term care facilities (LTCF) is an important public health issue, especially regarding its potential role in antimicrobial resistance. Up to two thirds of long-stay LTCF residents receive antimicrobial therapy each year. However, little is known specifically about antimicrobial use in short-stay LTCF residents receiving post-acute care. METHODS: The authors conducted a retrospective chart review of a random sample of residents admitted for post-acute care in seven LTCFs in Georgia from September 1, 1999 to August 31, 2000 to determine the rates and characteristics of antimicrobial prescribing in this population. RESULTS: Of 221 post-acute care residents, 105 (48%) received 152 courses of antimicrobial therapy during their post-acute stay. At least one antimicrobial was prescribed on 796 of 5220 resident-days (15%). Antimicrobial therapy was split evenly between hospital-initiated antimicrobial therapy (n = 53, 50%) and antimicrobial therapy initiated in the LTCF during post-acute care (n = 52, 50%). Levofloxacin was the most commonly prescribed antimicrobial. Where documentation on the suspected infection was present, the most common infections were urinary tract infections (UTIs) and pneumonias. For residents with post-acute care-initiated therapy, documentation regarding the presumed source of infection was absent for 44% of antimicrobial prescriptions. Most antimicrobial courses initiated for presumed infections in post-acute care were by telephone orders (66%). CONCLUSIONS: Utilization of antimicrobial therapy in LTCF residents in post-acute care is relatively high and may be greater than for long-stay LTCF residents. For hospital-initiated therapy, improved communication between hospital and LTCF staff may improve documentation and antimicrobial therapy in LTC. For antimicrobial therapy initiated by telephone orders in post-acute care, improving documentation of suspected source of infection is needed.
BACKGROUND: Antimicrobial use in long-term care facilities (LTCF) is an important public health issue, especially regarding its potential role in antimicrobial resistance. Up to two thirds of long-stay LTCF residents receive antimicrobial therapy each year. However, little is known specifically about antimicrobial use in short-stay LTCF residents receiving post-acute care. METHODS: The authors conducted a retrospective chart review of a random sample of residents admitted for post-acute care in seven LTCFs in Georgia from September 1, 1999 to August 31, 2000 to determine the rates and characteristics of antimicrobial prescribing in this population. RESULTS: Of 221 post-acute care residents, 105 (48%) received 152 courses of antimicrobial therapy during their post-acute stay. At least one antimicrobial was prescribed on 796 of 5220 resident-days (15%). Antimicrobial therapy was split evenly between hospital-initiated antimicrobial therapy (n = 53, 50%) and antimicrobial therapy initiated in the LTCF during post-acute care (n = 52, 50%). Levofloxacin was the most commonly prescribed antimicrobial. Where documentation on the suspected infection was present, the most common infections were urinary tract infections (UTIs) and pneumonias. For residents with post-acute care-initiated therapy, documentation regarding the presumed source of infection was absent for 44% of antimicrobial prescriptions. Most antimicrobial courses initiated for presumed infections in post-acute care were by telephone orders (66%). CONCLUSIONS: Utilization of antimicrobial therapy in LTCF residents in post-acute care is relatively high and may be greater than for long-stay LTCF residents. For hospital-initiated therapy, improved communication between hospital and LTCF staff may improve documentation and antimicrobial therapy in LTC. For antimicrobial therapy initiated by telephone orders in post-acute care, improving documentation of suspected source of infection is needed.
Authors: Sarah Kabbani; Adam L Hersh; Daniel J Shapiro; Katherine E Fleming-Dutra; Andrew T Pavia; Lauri A Hicks Journal: Clin Infect Dis Date: 2018-09-28 Impact factor: 9.079
Authors: Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson Journal: Infect Control Hosp Epidemiol Date: 2008-09 Impact factor: 3.254
Authors: Darcy K McMaughan; Obioma Nwaiwu; Hongwei Zhao; Elizabeth Frentzel; David Mehr; Sara Imanpour; Steven Garfinkel; Charles D Phillips Journal: BMC Geriatr Date: 2016-04-15 Impact factor: 3.921
Authors: Norihiro Yogo; Gregory Gahm; Bryan C Knepper; William J Burman; Philip S Mehler; Timothy C Jenkins Journal: Front Med (Lausanne) Date: 2016-07-21
Authors: Charles D Phillips; Omolola Adepoju; Nimalie Stone; Darcy K McMaughan Moudouni; Obioma Nwaiwu; Hongwei Zhao; Elizabeth Frentzel; David Mehr; Steven Garfinkel Journal: BMC Geriatr Date: 2012-11-23 Impact factor: 3.921
Authors: Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson Journal: Am J Infect Control Date: 2008-09 Impact factor: 2.918
Authors: Kyle J Gontjes; Kristen E Gibson; Bonnie J Lansing; Julia Mantey; Karen M Jones; Marco Cassone; Joyce Wang; John P Mills; Lona Mody; Payal K Patel Journal: JAMA Netw Open Date: 2022-02-01